© Reuters. BURLINGAME, Calif. – Corvus Pharmaceuticals, Inc. (NASDAQ: NASDAQ:), a biopharmaceutical company in the clinical stage, announced today that…
Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution. Cardio Diagnostics CDIO, an…